| Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care (NCT05226260) | Nationwide Children's Hospital | 2021-11-01 |
| Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo (NCT03429595) | UNION therapeutics | 2018-02-23 |
| Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (NCT03177993) | Washington University School of Medicine | 2017-07-13 |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo (NCT02902822) | Centro Studi Gised | 2016-10-01 |
| Azithromycin - Ivermectin Mass Drug Administration for Skin Disease (NCT02775617) | London School of Hygiene and Tropical Medicine | 2016-07-01 |
| Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo (NCT02090764) | Ferrer Internacional S.A. | 2014-06-01 |
| Safety and Efficacy of Mupirocin Gel in Children With Impetigo (NCT04287777) | Reig Jofre Group | 2014-02-01 |
| The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial (NCT01943136) | Philippine Dermatological Society | 2013-08-01 |
| Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo (NCT01670032) | NovaBay Pharmaceuticals, Inc. | 2012-08-01 |
| Citriodiol® and Impetigo (NCT01611909) | Royal North Shore Hospital | 2012-07-01 |
| Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo (NCT01397461) | Ferrer Internacional S.A. | 2012-03-01 |
| Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients (NCT01171326) | Vyne Therapeutics Inc. | 2010-08-01 |
| Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection (NCT01126268) | The University of Texas Health Science Center, Houston | 2010-04-01 |
| Safety and Efficacy of Topical NVC-422 Gel in Impetigo (NCT01367314) | NovaBay Pharmaceuticals, Inc. | 2009-08-01 |
| The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo (NCT00758862) | LEO Pharma | 2008-12-01 |
| EU PV for Retapamulin-Prescribing (NCT01153828) | GlaxoSmithKline | 2008-11-01 |
| Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment (NCT00133848) | GlaxoSmithKline | 2005-04-01 |
| Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory (NCT00884728) | Menzies School of Health Research | 2004-09-01 |